Ibn Sina Hospital
32
1
1
28
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.3%
2 terminated/withdrawn out of 32 trials
93.3%
+6.8% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 28 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (32)
AI Model for Bone Mineral Density Prediction From X-Ray Images
Role: collaborator
Efficacy of Transforaminal Epidural Steroid and Its Combination With Ozone in Lumbar Radiculopathy
Role: lead
Triple-arm pH Comparison
Role: lead
Progestin Priming Ovarian Stimulation (PPOS) Compared With Antagonist Protocol for Freeze-all Cycles
Role: lead
Cleave-stage Transfer on Day 3 Versus Day 5 Transfer When Only One Embryo Available
Role: lead
Utilizing Free DNA in Embryo Culture for PGT
Role: collaborator
Effect of Protein Concentration on Human Embryo Development
Role: lead
Humidified Culture and Live Birth After ICSI
Role: lead
Magnetic Nanoparticle Sperm Separation for Teratozoospermia Male and Women Older Than 35 Years
Role: lead
Laser-assisted ICSI Versus Conventional ICSI
Role: lead
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin B
Role: lead
Oocyte Vitrification Aided With Cytochalasin B
Role: lead
Using Cumulase for Denudation of Cycles With ≤ 8 Cumulus-oocytes Complexes
Role: lead
Whether Using Sequential pH Would Improve Human Blastocyst Formation
Role: lead
Oocyte Vitrification Aided With Latrunculin A
Role: lead
Sequential Versus Single O2 Levels on Human Embryo Development
Role: lead
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)
Role: lead
Handling Medium for ICSI With Ionomycin and Latrunculin A
Role: lead
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)
Role: lead
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)
Role: lead